Show simple item record

dc.contributorLazaar, H. Ben GobraneEN
dc.contributorAounallah Skhiri, H.EN
dc.contributorOueslati, F.EN
dc.contributorFrikha, H.EN
dc.contributorAchour, N.EN
dc.contributorHsairi, M.EN
dc.date.accessioned2014-06-17T09:12:21Z
dc.date.available2014-06-17T09:12:21Z
dc.date.issued2010EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/V16/06/16_6_2010_0602_0608.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/117925
dc.description602-608EN
dc.description.abstractWe aimed to identify the most appropriate screening strategy for cervical cancer [‎periodicity of 3, 5 or 10 years]‎ for Tunisia, taking into consideration the incidence of the disease, costs of screening and economic implications. We simulated follow-up of a fictitious cohort of 1 million women 35-39 years over 30 years. Computation of yearly medical care costs was based on data from medical files of patients diagnosed with cervical cancer in 2004 at the National Institute of Cancer, Tunis. For a 60% coverage level of screening, cervical cancer reduction would be 49.2% for a 3-year periodicity. The reduction would be 40.3% and 33.1% for 5 and 10 years periodicity respectively. Considering cost-effectiveness, 10-year screening gave the lowest annual cost to avoid 1 cervical cancer caseEN
dc.language.isofrEN
dc.relation.ispartofseriesEMHJ - Eastern Mediterranean Health Journal, 16 (‎6)‎, 602-608, 2010EN
dc.subjectUterine Cervical NeoplasmsEN
dc.subjectMass ScreeningEN
dc.subjectCost-Benefit AnalysisEN
dc.subjectIncidenceEN
dc.subject.meshUterine Cervical NeoplasmsEN
dc.title[‎Cost-effectiveness analysis of screening strategies for cervical cancer in Tunisia]‎EN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record